Johnson & Johnson could become the second biopharma company to achieve $100 billion in annual sales. The healthcare leader has a robust and diversified business that can support its dividend program.

Runway Growth Finance trades at a deep discount to NAV, reflecting persistent portfolio challenges and limited growth ...

This overlooked TSX stock shows how temporary market pressure can open the door to long-term opportunity. The post The ...

Down almost 40% from all-time highs, Goeasy is a financial services company that could double your TFSA contribution in 12 ...

At a 7.2% yield, South Bow (TSX:SOBO) stock's dividend is a fortress built on secure cash flow, disciplined debt targets, and ...

These two high-quality dividend stocks offer high yields and are incredibly safe, making them perfect for Canadian retirees.

Investing in quality energy stocks such as CNQ and BEP can help you benefit from a growing dividend yield and capital gains. The post Better Energy Stock: Canadian Natural Resources vs. Brookfield ...

BCE (TSX:BCE) stock could be a great value buy at these depths. The post Where Will BCE Stock Be in 5 Years? appeared first on The Motley Fool Canada.

The Institute of Social and Economic Research at UAA analyzed the side effects of various taxes and cuts being considered for a long-term state budget-balancing plan.

Today’s financial climate appears cautiously optimistic, with selective strength in technology, green energy and quality ...

In the year ahead, restaurants are focused on restoring traffic and preserving profit margins after a rocky 2025. With ...

As such, section 4C as applies to capital gains under section 37A and Rules of the Eighth Schedule, Income Tax Ordinance, 2001 is held to be applicable thereto, being within the ambit of section 4C (2 ...